In contrast, TFEB is hyperactivated and plays a pathogenic role in some cancers, including Birt-Hogg-Dubé (BHD) syndrome [84], TFEB translocation renal cell carcinoma [14, 91], and pancreatic cancer [92]. This evidence concerns the gene TFEB and hereditary clear cell renal cell carcinoma.